JOHN B. HENNEMAN III - 09 Jul 2024 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
Director
Signature
/s/ John B. Henneman, III
Issuer symbol
ANIK
Transactions as of
09 Jul 2024
Net transactions value
$0
Form type
4
Filing time
11 Jul 2024, 16:33:05 UTC
Previous filing
21 Jun 2024
Next filing
19 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Award $0 +5,771 +19% $0.000000 35,707 09 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2025 annual meeting of the Company's stockholders or July 9, 2025.